Search

You searched for "Refractive"

2041 results found

Brave new world

3 June 2024 |
It’s a great honour to be handed the editorial relay baton by Professor Bal Dhillon and I hope I don’t fumble it along the way. As I put pen to paper, I reflect on Bal’s signing off in the last...

The role of inflammation in the pathophysiology of DMO

1 February 2016 | | EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is a major cause of visual loss in diabetes, with a complex multifactorial pathogenesis. In the UK alone it is estimated that there are nearly 2.5 million diabetic patients aged over 12 years. Approximately 65,000 of...

Understanding the inequalities of ophthalmic care for Indigenous people in a first world country

6 November 2023 | | EYE - Pathology, EYE - Oncology
Aboriginal Australians have faced numerous challenges over the past centuries. Here in this article, Edward Saxton highlights why there are inequalities of ophthalmic care in Australia and why this has led to increased levels of blindness in Aboriginal people relative...

Part 1: Good news, bad news at the international conference

3 June 2024 | | EYE - General
One of my favourite comic strips from my childhood was Good News, Bad News which ran in Jackpot comic from 1979–1982. In this strip, the story for the main character would be described in a series of alternating ‘Good News’...

Tackling diabetic retinopathy globally through the VISION 2020 LINKS Diabetic Retinopathy Network

1 February 2017 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
It is abundantly clear that the burden of diabetes is rapidly increasing, as there are now 415 million adults with diabetes in the world, with a projected rise to 642 million by 2040 [1]. This equates to 1 in 10...

New solutions in the prevention and treatment of Acanthamoeba keratitis

5 October 2020 | | EYE - Cornea, EYE - General
The global increase in Acanthamoeba keratitis infections has emphasised the inefficiencies of current treatment and preventative methods, here researchers from the West of Scotland detail a promising new series of compounds that may stem the tide. News headlines detailing horror...

Advanced level practice for ophthalmic nursing

4 December 2025 | | EYE - General
The Royal College of Nursing (RCN) Ophthalmic Nursing Forum (ONF) is committed to clinical excellence through advancing ophthalmic nursing practice and supporting career development. With the increasing demand for ophthalmic services, advanced and specialist practice roles are vital to increase...

Immunoglobulin G4-related ophthalmic disease – what is it? (Part 2)

3 April 2023 |
Part 2: Clinical presentation and treatment (see part 1 here) Introduction IgG4-related disease (IgG4-RD) is understood to have a vast clinicopathological spectrum; nearly every organ has had reported involvement. Similarly, IgG4-related ophthalmic disease (IgG4-ROD) is known to affect nearly every...

It’s not always GCA

7 December 2020 | | EYE - Neuro-ophthalmology, EYE - General
Giant cell arteritis (GCA) is an immune mediated granulomatous inflammatory disease that affects muscular middle or large sized arteries. It is considered as a continuation of polymyalgia rheumatica (PMR) when the severity of the disease has increased. It is the...

Hidden eyelid laceration following blunt trauma

3 April 2024 | | EYE - Oculoplastic, EYE - Cornea, EYE - General
A paediatric case report of a hidden eyelid laceration following blunt trauma. Blunt injury to the eyelid can result in a multitude of issues, such as damage to the eyelid margin, lacrimal system and surrounding orbit [1]. These can often...

A unique case of macular burn from ‘toy’ laser

2 February 2024 | | EYE - General
The first laser was created in 1960 and its name is an acronym for ‘light amplification by stimulated emission of radiation’. Laser technology has been used for medical, industrial, research and entertainment purposes in a variety of fields following extensive...

A case of ‘60-day glaucoma’

3 April 2023 | | EYE - General
Neovascular glaucoma (NVG) has been called ‘90-’ or ‘100-day glaucoma’ in the past due to its typical development three months after the onset of central retinal vein occlusion (CRVO). In reality, NVG can occur anywhere between two weeks and two...